GlassScriptPhysician profile
Evette Shaner
NPI 1790175834
$12,144.66
in general payments reported to CMS, 2019-2025
48 companies · $3,783 in 2025
The $3,783 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,723 · 2022: $1,765 · 2023: $1,989 · 2024: $2,883 · 2025: $3,783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,865 · Travel and Lodging: $2,232 · Education: $559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,864.78 |
| Travel and Lodging | $2,232.46 |
| Education | $558.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,174.95 | 2023-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $1,367.39 | 2021-2025 | Airsupra, Tezspire, Breztri |
| Jazz Pharmaceuticals INC. | $1,161.03 | 2021-2025 | |
| Glaxosmithkline, LLC. | $1,018.91 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Harmony Biosciences LLC | $783.08 | 2021-2025 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $541.79 | 2021-2024 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Avadel Cns Pharmaceuticals, LLC | $474.22 | 2024-2025 | Lumryz |
| Axsome Therapeutics, INC. | $304.58 | 2023-2025 | Sunosi |
| United Therapeutics Corporation | $295.41 | 2021-2025 | Tyvaso, Tyvaso |
| Baxter Healthcare | $294.15 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Vest System Model 205 Acute Care |
| Regeneron Healthcare Solutions, INC. | $282.67 | 2022-2025 | Dupixent |
| Mylan Specialty L.P. | $268.49 | 2021-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $240.14 | 2021-2025 | Glassia |
| Philips North America LLC | $182.65 | 2021-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Genzyme Corporation | $161.23 | 2022-2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $147.80 | 2021-2025 | Smartvest |
| Grifols USA, LLC | $144.57 | 2021-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $114.21 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $99.95 | 2025 | |
| Medtronic, INC. | $76.51 | 2022 | |
| Amgen INC. | $72.27 | 2022-2023 | Tezspire |
| Inogen, INC. | $71.23 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Verona Pharma, INC. | $69.80 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $69.66 | 2025 | Yupelri |
| Genentech USA, INC. | $69.26 | 2023-2025 | Xolair |
| Mallinckrodt Hospital Products INC. | $65.80 | 2021 | |
| Astellas Pharma US INC | $65.15 | 2021 | |
| Insmed, INC. | $55.19 | 2025 | Arikayce, Brinsupri |
| Vanda Pharmaceuticals INC. | $52.25 | 2022 | |
| Janssen Pharmaceuticals, INC | $50.15 | 2021-2023 | Xarelto |
| Advanced Respiratory, INC | $37.12 | 2021 | |
| Alexion Pharmaceuticals, INC. | $33.91 | 2025 | Ultomiris |
| Teva Pharmaceuticals USA, INC. | $29.27 | 2021-2022 | |
| Resmed Corp | $27.70 | 2023 | |
| Abbvie INC. | $23.16 | 2023 | |
| Tactile Systems Technology INC | $21.19 | 2022 | |
| Ani Pharmaceuticals, INC. | $20.17 | 2024 | Purified Cortrophin Gel |
| Bayer Healthcare Pharmaceuticals INC. | $18.69 | 2022 | |
| La Jolla Pharmaceutical Company | $18.64 | 2025 | Giapreza |
| Covis Pharma Gmbh | $17.88 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $17.77 | 2021 | |
| Lilly USA, LLC | $16.77 | 2025 | Zepbound |
| Apria Healthcare LLC | $15.91 | 2021 | |
| Zoll Respicardia, INC. | $15.84 | 2025 | Remede System |
| Pulmonx Corporation | $15.35 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Phadia US INC. | $15.24 | 2022 | |
| Sunovion Pharmaceuticals INC. | $13.86 | 2021 | |
| Pfizer INC. | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evette Shaner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.